Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection

Abstract Background The recent rise and spread of carbapenem-resistant pathogens pose an urgent threat to public health and has fueled the search for new therapies. Localized delivery of topical antibiotics is an alternative for the treatment of infected wounds caused by drug-resistant pathogens. In...

Full description

Bibliographic Details
Main Authors: Sun Hee Moon, Yihong Kaufmann, Ryoichi Fujiwara, En Huang
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Microbiology
Subjects:
Online Access:https://doi.org/10.1186/s12866-021-02383-z
_version_ 1818343073602600960
author Sun Hee Moon
Yihong Kaufmann
Ryoichi Fujiwara
En Huang
author_facet Sun Hee Moon
Yihong Kaufmann
Ryoichi Fujiwara
En Huang
author_sort Sun Hee Moon
collection DOAJ
description Abstract Background The recent rise and spread of carbapenem-resistant pathogens pose an urgent threat to public health and has fueled the search for new therapies. Localized delivery of topical antibiotics is an alternative for the treatment of infected wounds caused by drug-resistant pathogens. In this study, we aimed to develop antimicrobial-loaded hydrogels for topical treatment of wound infections in a murine skin wound infection. Results Paenipeptin analogue 1, a linear lipopeptide, potentiated clarithromycin against multidrug-resistant Acinetobacter baumannii, Enterobacter cloacae, Escherichia coli, and Klebsiella pneumoniae. Enzymatically-crosslinked gelatin hydrogels were developed to encapsulate paenipeptin analogue 1 and clarithromycin. The encapsulated antimicrobials were gradually released from hydrogels during incubation, reaching 75.43 and 53.66% for paenipeptin and clarithromycin, respectively, at 24 h. The antimicrobial-loaded hydrogels containing paenipeptin and clarithromycin synergistically resulted in 5-log reduction in carbapenem-resistant A. baumannii within 6 h in vitro. Moreover, the antimicrobial-loaded hydrogels reduced 3.6- and 2.5-log of carbapenem-resistant A. baumannii when treated at 4 or 20 h post infection, respectively, in a murine skin wound infection. Conclusions Enzymatically-crosslinked gelatin hydrogels loaded with paenipeptin analogue 1 and clarithromycin exhibited potent therapeutic efficacy against carbapenem-resistant A. baumannii in murine skin wound infection.
first_indexed 2024-12-13T16:24:47Z
format Article
id doaj.art-758f23ed699546a687f8130baee2590e
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-12-13T16:24:47Z
publishDate 2021-11-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-758f23ed699546a687f8130baee2590e2022-12-21T23:38:38ZengBMCBMC Microbiology1471-21802021-11-012111710.1186/s12866-021-02383-zEnzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infectionSun Hee Moon0Yihong Kaufmann1Ryoichi Fujiwara2En Huang3Department of Environmental and Occupational Health, University of Arkansas for Medical SciencesDepartment of Environmental and Occupational Health, University of Arkansas for Medical SciencesDepartment of Pharmaceutical Sciences, University of Arkansas for Medical SciencesDepartment of Environmental and Occupational Health, University of Arkansas for Medical SciencesAbstract Background The recent rise and spread of carbapenem-resistant pathogens pose an urgent threat to public health and has fueled the search for new therapies. Localized delivery of topical antibiotics is an alternative for the treatment of infected wounds caused by drug-resistant pathogens. In this study, we aimed to develop antimicrobial-loaded hydrogels for topical treatment of wound infections in a murine skin wound infection. Results Paenipeptin analogue 1, a linear lipopeptide, potentiated clarithromycin against multidrug-resistant Acinetobacter baumannii, Enterobacter cloacae, Escherichia coli, and Klebsiella pneumoniae. Enzymatically-crosslinked gelatin hydrogels were developed to encapsulate paenipeptin analogue 1 and clarithromycin. The encapsulated antimicrobials were gradually released from hydrogels during incubation, reaching 75.43 and 53.66% for paenipeptin and clarithromycin, respectively, at 24 h. The antimicrobial-loaded hydrogels containing paenipeptin and clarithromycin synergistically resulted in 5-log reduction in carbapenem-resistant A. baumannii within 6 h in vitro. Moreover, the antimicrobial-loaded hydrogels reduced 3.6- and 2.5-log of carbapenem-resistant A. baumannii when treated at 4 or 20 h post infection, respectively, in a murine skin wound infection. Conclusions Enzymatically-crosslinked gelatin hydrogels loaded with paenipeptin analogue 1 and clarithromycin exhibited potent therapeutic efficacy against carbapenem-resistant A. baumannii in murine skin wound infection.https://doi.org/10.1186/s12866-021-02383-zCarbapenem-resistanceWound infectionPaenipeptinClarithromycinHydrogel
spellingShingle Sun Hee Moon
Yihong Kaufmann
Ryoichi Fujiwara
En Huang
Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection
BMC Microbiology
Carbapenem-resistance
Wound infection
Paenipeptin
Clarithromycin
Hydrogel
title Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection
title_full Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection
title_fullStr Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection
title_full_unstemmed Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection
title_short Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection
title_sort enzymatically crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem resistant pathogen in murine skin wound infection
topic Carbapenem-resistance
Wound infection
Paenipeptin
Clarithromycin
Hydrogel
url https://doi.org/10.1186/s12866-021-02383-z
work_keys_str_mv AT sunheemoon enzymaticallycrosslinkedgelatinhydrogelscontainingpaenipeptinandclarithromycinagainstcarbapenemresistantpathogeninmurineskinwoundinfection
AT yihongkaufmann enzymaticallycrosslinkedgelatinhydrogelscontainingpaenipeptinandclarithromycinagainstcarbapenemresistantpathogeninmurineskinwoundinfection
AT ryoichifujiwara enzymaticallycrosslinkedgelatinhydrogelscontainingpaenipeptinandclarithromycinagainstcarbapenemresistantpathogeninmurineskinwoundinfection
AT enhuang enzymaticallycrosslinkedgelatinhydrogelscontainingpaenipeptinandclarithromycinagainstcarbapenemresistantpathogeninmurineskinwoundinfection